Everest Medicines

Pharmaceutical ManufacturingNew York, United States51-200 Employees

Everest Medicines is a mid-sized pharmaceutical company based in New York City, New York. It concentrates on developing and marketing therapies for patients in mainland China and other parts of Asia. The company aims to partner with global innovators to bring medicines to the Greater China market and to pursue products with a high probability of regulatory approval.

Its team has experience in clinical development, regulatory affairs, CMC, and operations in China and in collaborations with international pharmaceutical firms. In June 2026, Everest Medicines announced an exclusive Asia-Pacific licensing arrangement with Jiangsu Vcare PharmaTech Co., Ltd to develop, register, and commercialize Sumecigrel across multiple Asia-Pacific markets, including Southeast Asia, South Korea, Australia, Hong Kong, Macau, and Taiwan.

Sign up for free to view info

Email Format Employee directory